metastatic breast cancer
Showing NaN - NaN of 64
Metastatic Breast Cancer Trial in United States (Ixabepilone, Carboplatin)
Completed
- Metastatic Breast Cancer
-
Phoenix, Arizona
- +58 more
Oct 14, 2016
Metastatic Breast Cancer Trial in United States (Pegylated liposomal doxorubicin, Carboplatin, trastuzumab)
Completed
- Metastatic Breast Cancer
- Pegylated liposomal doxorubicin
- +2 more
-
Birmingham, Alabama
- +56 more
Sep 15, 2016
Metastatic Breast Cancer, HER2+ Breast Cancer Trial in Worldwide (BKM120, Trastuzumab, Capecitabine)
Terminated
- Metastatic Breast Cancer
- HER2+ Breast Cancer
- BKM120
- +2 more
-
Birmingham, Alabama
- +20 more
Aug 9, 2016
Metastatic Breast Cancer Trial in United States (paclitaxel, pertuzumab [Perjeta], trastuzumab emtansine [Kadcyla])
Metastatic Breast Cancer Trial in Worldwide (Ixabepilone, 16 mg/m^2 + Bevacizumab, 10 mg/kg, Ixabepilone, 40 mg/m^2 +
Completed
- Metastatic Breast Cancer
- Ixabepilone, 16 mg/m^2 + Bevacizumab, 10 mg/kg
- +2 more
-
Burbank, California
- +24 more
Feb 9, 2016
Expressive Writing and Adjustment to Metastatic Breast Cancer
Completed
- Metastatic Breast Cancer
- Writing Intervention
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2015
Metastatic Breast Cancer Trial in Boston, New York, Essen (tivozanib (AV-951) + paclitaxel)
Completed
- Metastatic Breast Cancer
- tivozanib (AV-951) + paclitaxel
-
Boston, Massachusetts
- +2 more
Jun 27, 2012
Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (Gemcitabine, Bevacizumab)
Completed
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer
-
Fayetteville, Arkansas
- +15 more
Dec 2, 2011
Metastatic Breast Cancer, Advanced Breast Cancer Trial in Canada, United States (ertumaxomab)
Terminated
- Metastatic Breast Cancer
- Advanced Breast Cancer
-
Minneapolis, Minnesota
- +4 more
Apr 28, 2011